121 related articles for article (PubMed ID: 31078923)
1. Methionine enkephalin (MENK) regulates the immune pathogenesis of type 2 diabetes mellitus via the IL-33/ST2 pathway.
Zhang K; Yang J; Ao N; Jin S; Qi R; Shan F; Du J
Int Immunopharmacol; 2019 Aug; 73():23-40. PubMed ID: 31078923
[TBL] [Abstract][Full Text] [Related]
2. Novel effect of methionine enkephalin against influenza A virus infection through inhibiting TLR7-MyD88-TRAF6-NF-κB p65 signaling pathway.
Tian J; Jiao X; Wang X; Geng J; Wang R; Liu N; Gao X; Griffin N; Shan F
Int Immunopharmacol; 2018 Feb; 55():38-48. PubMed ID: 29220721
[TBL] [Abstract][Full Text] [Related]
3. Methionine enkephalin (MENK) mounts antitumor effect via regulating dendritic cells (DCs).
Meng Y; Gao X; Chen W; Plotnikoff NP; Griffin N; Zhang G; Shan F
Int Immunopharmacol; 2017 Mar; 44():61-71. PubMed ID: 28088065
[TBL] [Abstract][Full Text] [Related]
4. Novel modulation on myeloid-derived suppressor cells (MDSCs) by methionine encephalin (MENK).
Geng J; Yuan Y; Jiao X; Wang R; Liu N; Chen H; Griffin N; Shan F
Int Immunopharmacol; 2019 Mar; 68():193-203. PubMed ID: 30654309
[TBL] [Abstract][Full Text] [Related]
5. Methionine enkephalin inhibits influenza A virus infection through upregulating antiviral state in RAW264.7 cells.
Tian J; Qu N; Jiao X; Wang X; Geng J; Griffin N; Shan F
Int Immunopharmacol; 2020 Jan; 78():106032. PubMed ID: 31835089
[TBL] [Abstract][Full Text] [Related]
6. Induction on differentiation and modulation of bone marrow progenitor of dendritic cell by methionine enkephalin (MENK).
Liu J; Chen W; Meng J; Lu C; Wang E; Shan F
Cancer Immunol Immunother; 2012 Oct; 61(10):1699-711. PubMed ID: 22392190
[TBL] [Abstract][Full Text] [Related]
7. Methionine enkephalin, its role in immunoregulation and cancer therapy.
Zhao D; Plotnikoff N; Griffin N; Song T; Shan F
Int Immunopharmacol; 2016 Aug; 37():59-64. PubMed ID: 26927200
[TBL] [Abstract][Full Text] [Related]
8. A novel mechanism of lung cancer inhibition by methionine enkephalin through remodeling the immune status of the tumor microenvironment.
Zhang S; Huang H; Handley M; Griffin N; Bai X; Shan F
Int Immunopharmacol; 2021 Oct; 99():107999. PubMed ID: 34315116
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes.
Creely SJ; McTernan PG; Kusminski CM; Fisher fM; Da Silva NF; Khanolkar M; Evans M; Harte AL; Kumar S
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E740-7. PubMed ID: 17090751
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK).
Li W; Chen W; Herberman RB; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
Cancer Lett; 2014 Mar; 344(2):212-22. PubMed ID: 24291668
[TBL] [Abstract][Full Text] [Related]
11. Methionine enkephalin regulates microglia polarization and function.
Xu X; Gao Y; Wen L; Zhai Z; Zhang S; Shan F; Feng J
Int Immunopharmacol; 2016 Nov; 40():90-97. PubMed ID: 27584058
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the growth of human melanoma cells by methionine enkephalin.
Wang DM; Wang GC; Yang J; Plotnikoff NP; Griffin N; Han YM; Qi RQ; Gao XH; Shan FP
Mol Med Rep; 2016 Dec; 14(6):5521-5527. PubMed ID: 27878237
[TBL] [Abstract][Full Text] [Related]
13. Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment.
Wang X; Li S; Yan S; Shan Y; Wang X; Jingbo Z; Wang Y; Shan F; Griffin N; Sun X
Int Immunopharmacol; 2022 Oct; 111():109125. PubMed ID: 35988519
[TBL] [Abstract][Full Text] [Related]
14. Methionine enkephalin (MENK) inhibits human gastric cancer through regulating tumor associated macrophages (TAMs) and PI3K/AKT/mTOR signaling pathway inside cancer cells.
Wang X; Jiao X; Meng Y; Chen H; Griffin N; Gao X; Shan F
Int Immunopharmacol; 2018 Dec; 65():312-322. PubMed ID: 30343258
[TBL] [Abstract][Full Text] [Related]
15. Rules to activate CD8
Jiao X; Wang X; Wang R; Geng J; Liu N; Chen H; Griffin N; Shan F
Int Immunopharmacol; 2018 Dec; 65():76-83. PubMed ID: 30290369
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory and metabolic reprogramming effects of MENK produce antitumor response in CT26 tumor-bearing mice.
Tuo Y; Zhang Z; Tian C; Hu Q; Xie R; Yang J; Zhou H; Lu L; Xiang M
J Leukoc Biol; 2020 Jul; 108(1):215-228. PubMed ID: 31994797
[TBL] [Abstract][Full Text] [Related]
17. Arachidonic acid and lipoxinA4 attenuate streptozotocin-induced cytotoxicity to RIN5 F cells in vitro and type 1 and type 2 diabetes mellitus in vivo.
Gundala NKV; Naidu VGM; Das UN
Nutrition; 2017 Mar; 35():61-80. PubMed ID: 28241993
[TBL] [Abstract][Full Text] [Related]
18. The paradoxical role of methionine enkephalin in tumor responses.
Tuo Y; Tian C; Lu L; Xiang M
Eur J Pharmacol; 2020 Sep; 882():173253. PubMed ID: 32535097
[TBL] [Abstract][Full Text] [Related]
19. Functional modulation of the pathway between dendritic cells (DCs) and CD4+T cells by the neuropeptide: methionine enkephalin (MENK).
Shan F; Xia Y; Wang N; Meng J; Lu C; Meng Y; Plotnikoff NP
Peptides; 2011 May; 32(5):929-37. PubMed ID: 21335041
[TBL] [Abstract][Full Text] [Related]
20. The TLR2 ligand FSL-1 and the TLR5 ligand Flagellin mediate pro-inflammatory and pro-labour response via MyD88/TRAF6/NF-κB-dependent signalling.
Lim R; Barker G; Lappas M
Am J Reprod Immunol; 2014 May; 71(5):401-17. PubMed ID: 24635133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
